Read the latest reports on Western Europe, with local insight, sp...
Read the latest reports on Western Europe, with local insight, specialist knowledge and a comprehensive breakdown of key market data. Our research identifies key strategic themes relevant across the region, while also providing a more granular unders...
Consumer health witnessed a solid performance in 2023, with current value growth gaining momentum for the fourth consecutive year. Overall there has been little change in the price of OTC products, despite the slightly higher inflation rate in 2023,…
The Coronavirus (COVID-19) pandemic had a major impact on almost every category within consumer health in the Netherlands. While the COVID-19 situation eased by 2022, 2023 is the first full year after the pandemic in which players, retailers and…
Consumer health continues to experience high retail current value growth in 2023, albeit at a slower rate than 2022. Higher costs of materials, ingredients and services are naturally leading to strong price increases in 2023, thereby driving up value…
Economic instability, characterised by very high inflation, continues to restrain retail volume sales at the end of the review period. The Turkish economy is taking longer than many other countries to recover from the economic effects of Coronavirus…
Cough, cold and allergy (hay fever) remedies received a strong sales boost in 2022 due to consumers returning to working in the office more frequently again and kids returning to in-school classes. This led to consumers spending more time among other…
Sales of cough, cold and allergy (hay fever) remedies are seeing strong growth in current value terms in 2023. This is partly due to inflation-driven price increases (also the consequence of supply shortages in some cases) and an increase in cough,…
Cough remedies and decongestants, which had seen strong growth during the pandemic period, saw more moderate growth in 2022 and 2023 as the contagion receded and public concern waned. Current value sales growth partly reflects inflationary pressures,…
Cough, cold and allergy (hay fever) sales are expected to be slightly down in 2023. This is partly a result of the very strong performance seen in the previous year, as the lifting of COVID-19 related restrictions led to greater social contact and…
Within OTC consumer health in France, value sales of cough, cold and allergy (hay fever) remedies are continuing to record the fastest growth in 2023, following a dynamic performance the previous year. Within the category, demand for various formats…
Cough and cold remedies were recording see high single-digit growth in current value terms in 2023, with sales benefiting from the large number of cases of cold and flu in the 2023/2024 season. Furthermore, value sales were also being boosted by unit…